Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs BLISS GVS PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES BLISS GVS PHARMA SUVEN LIFE SCIENCES/
BLISS GVS PHARMA
 
P/E (TTM) x -20.5 13.1 - View Chart
P/BV x 5.8 1.3 429.8% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 SUVEN LIFE SCIENCES   BLISS GVS PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
BLISS GVS PHARMA
Mar-23
SUVEN LIFE SCIENCES/
BLISS GVS PHARMA
5-Yr Chart
Click to enlarge
High Rs9491 102.6%   
Low Rs4567 66.9%   
Sales per share (Unadj.) Rs0.672.2 0.9%  
Earnings per share (Unadj.) Rs-5.47.4 -73.6%  
Cash flow per share (Unadj.) Rs-5.19.2 -55.9%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs17.284.0 20.5%  
Shares outstanding (eoy) m218.07104.15 209.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.81.1 10,166.5%   
Avg P/E ratio x-12.810.8 -118.8%  
P/CF ratio (eoy) x-13.58.7 -156.4%  
Price / Book Value ratio x4.00.9 427.0%  
Dividend payout %06.8 -0.0%   
Avg Mkt Cap Rs m15,1318,262 183.1%   
No. of employees `000NANA-   
Total wages/salary Rs m186862 21.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1357,516 1.8%  
Other income Rs m84178 47.5%   
Total revenues Rs m2207,694 2.9%   
Gross profit Rs m-1,1961,173 -102.0%  
Depreciation Rs m65187 35.0%   
Interest Rs m5104 5.2%   
Profit before tax Rs m-1,1831,061 -111.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0293 0.0%   
Profit after tax Rs m-1,183767 -154.1%  
Gross profit margin %-883.615.6 -5,660.7%  
Effective tax rate %027.7 -0.0%   
Net profit margin %-873.510.2 -8,555.9%  
BALANCE SHEET DATA
Current assets Rs m3,4556,974 49.5%   
Current liabilities Rs m1,0501,933 54.3%   
Net working cap to sales %1,776.067.1 2,647.9%  
Current ratio x3.33.6 91.2%  
Inventory Days Days3,94839 10,216.5%  
Debtors Days Days2181,871 11.6%  
Net fixed assets Rs m1,3734,562 30.1%   
Share capital Rs m218104 209.4%   
"Free" reserves Rs m3,5358,646 40.9%   
Net worth Rs m3,7538,750 42.9%   
Long term debt Rs m0407 0.0%   
Total assets Rs m4,82811,535 41.9%  
Interest coverage x-218.811.2 -1,947.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.7 4.3%   
Return on assets %-24.47.6 -322.9%  
Return on equity %-31.58.8 -359.3%  
Return on capital %-31.412.7 -246.7%  
Exports to sales %40.40-   
Imports to sales %839.80-   
Exports (fob) Rs m55NA-   
Imports (cif) Rs m1,137NA-   
Fx inflow Rs m555,618 1.0%   
Fx outflow Rs m1,1371,225 92.9%   
Net fx Rs m-1,0824,394 -24.6%   
CASH FLOW
From Operations Rs m-1,031343 -300.6%  
From Investments Rs m-2,606-78 3,362.7%  
From Financial Activity Rs m3,955-249 -1,586.0%  
Net Cashflow Rs m31730 1,051.2%  

Share Holding

Indian Promoters % 69.6 35.0 198.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 22.0 2.5%  
FIIs % 0.5 15.4 3.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 65.0 46.8%  
Shareholders   74,003 40,758 181.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs BLISS GVS PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs BLISS GVS PHARMA Share Price Performance

Period Suven Life Sciences BLISS GVS PHARMA S&P BSE HEALTHCARE
1-Day 0.30% -1.31% 1.18%
1-Month -2.06% -9.12% -0.75%
1-Year 114.92% 58.26% 61.82%
3-Year CAGR 14.94% 3.89% 18.16%
5-Year CAGR -16.22% -8.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the BLISS GVS PHARMA share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of BLISS GVS PHARMA the stake stands at 35.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of BLISS GVS PHARMA.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

BLISS GVS PHARMA paid Rs 0.5, and its dividend payout ratio stood at 6.8%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of BLISS GVS PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.